Navigation Links
IPC The Hospitalist Company Reports Record First Quarter 2009 Results
Date:5/4/2009

NORTH HOLLYWOOD, Calif., May 4 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice, today announced financial results for the first quarter ended March 31, 2009.

First Quarter 2009 Highlights (comparisons are to first quarter 2008):

  • Net revenue increased 26% to $76.1 million, with same-market area net revenue growth of 19%

  • Patient encounters increased 18% to 810,000

  • Income from operations rose 39% to $7.6 million

  • Operating margin improved 90 basis points to 9.9%

  • Net income increased 50% to $4.5 million, or $0.28 per diluted share for the quarter

Adam D. Singer, M.D., Chief Executive Officer of IPC The Hospitalist Company, stated, "Our record results for the first quarter of 2009 reflect IPC's continued ability to generate strong revenue growth and expand operating margin. The first quarter revenue growth of 26% was driven by increased penetration of same-market areas, as well as the contribution from IPC's entry into its newest market in Southeast Florida. As we grow our revenue base, we have a significant opportunity to leverage our general and administrative costs, as evidenced by the 90 basis point improvement in our operating margin. We also continued to strengthen our balance sheet by increasing our cash flow and reducing our days sales outstanding, which resulted in an increase in our cash balance."

Dr. Singer added, "In line with our growth strategy, we are aggressively continuing to recruit new physicians to add to our existing practices. In the first quarter, we also completed two in-market acquisitions in Phoenix, which strengthened our foothold in one of our largest markets. Our acquisition pipeline remains robust in this highly fragmented industry, and we continue to evaluate opportunities across the hospitalist sector. We remain confident that we can continue to grow and penetrate current and new markets through this combination of organic growth and acquisitions. With less than 5% of our encounters coming from elective in-patient stays and uninsured patients remaining stable at approximately 7% of our encounters, we believe we are very well positioned in this challenging economic environment."

First Quarter 2009

IPC's first quarter 2009 patient encounters rose 18% to 810,000, compared to 684,000 in the same period last year. Net revenue for the first quarter was $76.1 million, an increase of $15.5 million, or 25.6%, from $60.6 million for the prior year quarter. Of this $15.5 million increase, $11.8 million, or 76.1%, was attributable to same-market area growth and $3.7 million was attributable to revenue generated from a new market acquisition, which was completed in the third quarter of 2008. The change in same-market area net revenue was the result of an 11.9% increase in patient encounters, a 5.9% increase in patient revenue per encounter and an increase in hospital contract revenue. The increase in patient revenue per encounter was partially due to an increase in Medicare reimbursement rates for the billing codes applicable to the services performed by the Company's hospitalists, as well as improvements in billing processes and collections.

Physician practice salaries, benefits and other expenses for the three months ended March 31, 2009 were $55.5 million, or 72.9%, of net revenue compared to $43.9 million, or 72.6%, of net revenue for the three months ended March 31, 2008. Physician costs as a percentage of net revenue increased slightly as a result of the costs associated with one hospital contract being operated at breakeven, as it is being staffed with locum tenens and other part-time providers at the hospital's request while IPC recruits employed staff. Excluding this contract, physician costs as a percentage of net revenue for the current quarter were at the same level as the prior year quarter.

General and administrative expenses for the first quarter of 2009 were $12.4 million, compared to $10.7 million for the first quarter of 2008. General and administrative expenses as a percentage of net revenue declined to 16.4% for the first quarter of 2009, compared to 17.7% for the first quarter of 2008, as the Company continues to leverage these costs over a larger revenue base as it grows its existing practices and continues to acquire new practices.

Income from operations for the first quarter of 2009 increased 39.4% to $7.6 million, compared to $5.4 million for the first quarter of 2008. The Company's operating margin rose to 9.9% for the first quarter of 2009, compared to 9.0% for the first quarter of 2008. The increase in operating margin was primarily the result of the reduction in general and administrative expenses as a percentage of net revenue.

The effective tax rate for the three months ended March 31, 2009 was 40.0%, compared to 42.0% for the three months ended March 31, 2008. The decrease in the effective tax rate reflected a new enterprise zone tax credit recorded for the first time in the fourth quarter of 2008. The Company expects its effective tax rate to remain at 40% for the remainder of 2009.

First quarter 2009 net income increased by 50% to $4.5 million, or $0.28 per diluted share, compared to $3.0 million, or $0.21 per pro-forma diluted share, for the first quarter of 2008.

Cash flow from operations for the first quarter of 2009 was $10.7 million, compared to $2.6 million for the same quarter of 2008. Days sales outstanding (DSO) decreased to 55 DSO at the end of the quarter, compared to 60 DSO as of December 31, 2008, as the Company continued to improve its billing processes and collections. During the quarter, the Company expended $4.8 million for physician practice acquisitions and earn-out payments attributable to practices acquired in 2007 and 2008.

Guidance

For the full year 2009, the Company continues to expect revenue to be in the range of $300 million to $305 million and earnings per diluted share to be in the range of $1.01 to $1.11. The Company has provided this outlook based on the following assumptions: (i) an estimated 4.6% increase in the weighted average reimbursement rates for services provided to Medicare patients; (ii) continued growth in same-market areas whether from new hires or in-market acquisitions; (iii) a 40% effective tax rate; and (iv) 16.3 million weighted average diluted shares outstanding for the year. Not included in the assumptions are (i) new market acquisitions; (ii) increased general and administrative expenses as a result of the requirement of FAS Statement 141(R) to expense external costs associated with acquisitions that close subsequent to December 31, 2008; and (iii) gains or losses related to changes in estimates of earn-outs related to acquisitions that close subsequent to December 31, 2008 as required by FAS Statement 141(R).

Conference Call Information

IPC The Hospitalist Company will host an investor conference call to review the quarterly results at 5:00 p.m. ET (2:00 p.m. PT) today. To participate in the conference call, please dial 877-879-6184 (USA) or 719-325-4789 (International). In addition, a dial-up replay of the conference call will be available beginning May 4, 2009 at 8:00 p.m. ET (5:00 p.m. PT) and ending on May 18, 2009. The replay telephone number is 888-203-1112 (USA) or 719-457-0820 (International) Replay Passcode: 9468818. A live webcast of the call will also be available from the Investor Relations section on the corporate website at http://www.hospitalist.com. A webcast replay can be accessed on the corporate website beginning May 4, 2009 at approximately 8:00 p.m. ET (5:00 p.m. PT) and will remain available until May 18, 2009 at 11:59 p.m.

About IPC The Hospitalist Company

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national hospitalist physician group practice focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com .

Safe Harbor Statement

Certain statements and information in this press release may be deemed to be "forward-looking statements" within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release may include, but are not limited to, those statements set forth under the section titled "Guidance" regarding projected operating results, revenues, earnings, and IPC's growth opportunities and strategy. Forward-looking statements are often characterized by terminology such as "believe", "hope", "may", "anticipate", "should", "intend", "plan", "will", "expect", "estimate", "project", "positioned", "strategy" and similar expressions. Any forward-looking statements are necessarily based on a variety of estimates and assumptions which, though considered reasonable by the Company, may not be realized and are inherently subject to significant business, economic, competitive, industry, regulatory, market and financial uncertainties and contingencies, many of which are and will be beyond IPC's control. Important risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by any forward-looking statements are described in IPC's most recent Annual Report on Form 10-K, including the section titled "Risk Factors" and actual results could differ materially from those anticipated in forward-looking statements.

In particular the following risks and uncertainties may have such an impact:

  • failure to comply with complex and intensive government regulation of our industry;

  • the adequacy of our insurance coverage and insurance reserves;

  • our ability to recruit and retain qualified physicians;

  • our ability to successfully integrate new acquisitions;

  • the effect of changes in rates or methods of third-party reimbursement; and

  • the high level of competition in our industry.

IPC undertakes no obligation following the date of this press release to update or revise any such statements or projections whether as a result of new information, future events, or otherwise.

                      IPC The Hospitalist Company, Inc.
                         Consolidated Balance Sheets
                     (in thousands, except for share data)

                                                      March 31,
                                                        2009       December
                                                     (unaudited)   31, 2008


      Assets
      Current assets:
              Cash and cash equivalents                $42,379     $37,394
              Accounts receivable, net                  46,035      44,474
              Prepaid expenses and other
               current assets                            5,117       8,081
                                                         -----       -----
      Total current assets                              93,531      89,949
      Furniture and equipment, net                       2,412       2,452
      Goodwill                                          70,752      63,893
      Other intangible assets, net                       2,758       2,905
      Deferred tax assets, net                           3,492       3,492
                                                         -----       -----
      Total assets                                    $172,945    $162,691
                                                      ========    ========

      Liabilities and Stockholders' Equity
      Current liabilities:
              Accounts payable and accrued
               liabilities                              $5,179      $4,664
              Accrued compensation                      14,317      11,232
              Payables for practice
               acquisitions                              4,616       2,476
              Medical malpractice and self-
               insurance reserves, current
               portion                                     351         539
              Deferred tax liabilities                     481         481
              Short-term debt and current
               portion of capital leases                 3,360       3,471
                                                         -----       -----
      Total current liabilities                         28,304      22,863
      Long-term debt and capital leases, less
       current portion                                   4,570       5,368
      Medical malpractice and self-insurance
       reserves, less current portion                   11,580      11,220
      Other long-term liabilities                          293         293
                                                           ---         ---
      Total liabilities                                 44,747      39,744
      Stockholders' equity:
              Preferred stock, $0.001 par value,
               15,000,000 shares authorized,
               none issued                                   -           -
              Common stock, $0.001 par value,
               50,000,000 shares authorized,
               16,091,345 and 16,068,835 shares
               issued and outstanding at March 31,
               2009 and December 31, 2008,
               respectively                                 16          16
              Additional paid-in capital               122,759     122,024
              Retained earnings                          5,423         907
                                                         -----         ---
      Total stockholders' equity                       128,198     122,947
                                                       -------     -------
      Total liabilities and stockholders'
       equity                                         $172,945    $162,691
                                                      ========    ========



                        IPC The Hospitalist Company, Inc.
                        Consolidated Statements of Income
                (dollars in thousands, except for per share data)
                                   (unaudited)

                                                           Three Months Ended
                                                               March 31,
                                                            ----------------
                                                            2009        2008
                                                            ----        ----

      Net revenue                                        $76,057     $60,559
      Operating expenses:
              Cost of services-physician practice
               salaries, benefits and other               55,461      43,943
              General and administrative                  12,441      10,732
              Depreciation and amortization                  588         457
                                                             ---         ---
      Total operating expenses                            68,490      55,132
                                                          ------      ------
      Income from operations                               7,567       5,427
      Investment income                                       41         164
      Interest expense                                       (79)       (385)
                                                             ---        ----
      Income before income taxes                           7,529       5,206
      Income tax provision                                 3,012       2,186
                                                           -----       -----
      Net income                                           4,517       3,020
      Income allocable to preferred stockholders               -        (696)
                                                             ---        ----
      Net income attributable to common stockholders      $4,517      $2,324
                                                          ======      ======

      Per share data:
      Net income per share attributable to common
       stockholders-historical:
      Price per share:
              Basic                                        $0.28       $0.20
                                                           =====       =====
              Diluted                                      $0.28       $0.20
                                                           =====       =====
      Weighted average shares:
              Basic                                   16,089,357  11,434,588
                                                      ==========  ==========
              Diluted                                 16,258,950  11,831,936
                                                      ==========  ==========
      Net income per share attributable to common
       stockholders-pro forma (1):
              Basic                                         N/A        $0.22
                                                           =====       =====
              Diluted                                       N/A        $0.21
                                                           =====       =====
      Weighted average shares
              Basic                                         N/A   13,975,526
                                                           =====  ==========
              Diluted                                       N/A   14,212,207
                                                           =====  ==========


    (1)  Pro forma per share information assumes conversion of our convertible
         preferred stock and associated warrants at the beginning of 2008
         based on the terms of the warrants and convertible preferred stock.



                     IPC The Hospitalist Company, Inc.
                   Consolidated Statements of Cash Flows
                          (dollars in thousands)
                               (unaudited)
                                                        Three Months
                                                       Ended March 31,
                                                      ----------------
                                                         2009     2008

      Operating activities
      Net income                                       $4,517   $3,020
      Adjustments to reconcile net income to net
       cash provided by operating activities:
              Depreciation and amortization               588      457
              Stock-based compensation expense            448      107
              Changes in assets and liabilities:
                    Accounts receivable                (1,561)  (3,327)
                    Prepaid expenses and other
                     current assets                     2,964    4,744
                    Accounts payable                      513   (1,097)
                    Accrued compensation                3,085   (1,984)
                    Medical malpractice and self-
                     insurance reserves                   172      729
                                                          ---      ---
      Net cash provided by operating activities        10,726    2,649
                                                       ------    -----
      Investing activities
      Acquisitions of physician practices              (4,792)  (3,452)
      Purchase of furniture and equipment                (327)    (495)
                                                         ----     ----
      Net cash used in investing activities            (5,119)  (3,947)
                                                       ------   ------
      Financing activities
      Repayments of long-term debt and capital
       leases, net                                       (909) (12,382)
      Net proceeds from issuance of common and
       preferred stock                                    270   46,131
      Excess tax benefits from stock-based
       compensation                                        17       74
                                                           --       --
      Net cash (used in) provided by financing
       activities                                        (622)  33,823
                                                         ----   ------

      Net increase in cash and cash equivalents         4,985   32,525
      Cash and cash equivalents, beginning of period   37,394    6,976
                                                       ------    -----
      Cash and cash equivalents, end of period        $42,379  $39,501
                                                      =======  =======



                     IPC The Hospitalist Company, Inc.
                              Operating Data

    Number of Patient Encounter Data (unaudited):

    The following is a summary of the quarterly patient encounters for the
    five quarters ended March 31, 2009:

                                           Quarter Ended:
                                           ---------------
                               Mar 31, Jun 30, Sep 30,  Dec 31, Mar 31,
                                 2008    2008     2008    2008     2009
                                 ----    ----     ----    ----     ----
      Patient encounters      684,000 660,000  692,000 754,000  810,000
                              ======= =======  ======= =======  =======


    Contacts:                             Amy Glynn/Nick Laudico
    Devra Shapiro                         The Ruth Group
    IPC The Hospitalist Company, Inc.     (646) 536-7023/7030
    (818) 766-3502                        aglynn@theruthgroup.com
                                          nlaudico@theruthgroup.com


'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. IPC The Hospitalist Company, Inc. to Report First Quarter 2009 Financial Results
2. IPC The Hospitalist Company Presents IPC Hospitalist of the Year Award to Tim Osonma, M.D.
3. IPC The Hospitalist Company Acquires Arizona Practice
4. Spokane Hospitals Engage Sound Inpatient Physicians(TM) as Hospitalists in Spokane
5. IPC The Hospitalist Company Adopts E-Proxy to Reduce Environmental Impact
6. IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results
7. IPC The Hospitalist Company Receives Best IPO Award from Los Angeles Venture Association
8. IPC The Hospitalist Company Acquires Missouri Practice Group
9. IPC The Hospitalist Company, Inc. to Present at 27th Annual J.P. Morgan Healthcare Conference
10. Physician Staffing Trends and Hospitalist Jobs Fuel Growth at Locum Leaders
11. IPC The Hospitalist Company Acquires Two Florida Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims to ... that are both engaging and easy to use. Coming off the heels of ... revealed today its plans to roll out new AI-powered self-service enhancements to help ...
(Date:12/8/2016)... ... ... California Senate Bill (SB) 863, signed into law in 2012, may have ... according to CompScope™ Medical Benchmarks for California, 17th Edition , a study by ... payments per claim in California decreased 4 percent in 2013 and then 3 percent ...
(Date:12/8/2016)... OH (PRWEB) , ... December 08, 2016 , ... ... insurance and financial planning services from offices headquartered in Hamilton County, is embarking ... rescue LuvFurMutts. , LuvFurMutts specializes in finding new homes for orphaned or neglected ...
(Date:12/8/2016)... ... 08, 2016 , ... Coffey Agencies, a locally owned and ... in the northern Alabama and Georgia regions, is embarking on a charity drive ... has built a network of support and education facilities to develop and provide ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , 8. Dezember 2016 Mederi Therapeutics Inc . hat die ... nicht-operative Behandlungsmethode für gastroösophageale Refluxerkrankung (GERD) – in China ... ... Live Stretta procedure performed ... Liu, Director of Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... Dignitana, a world leader in medical scalp-cooling technology, has ... the award-winning, patented Boa® system, to produce an adaptive, ... cooling system. DigniCap® was cleared by the U.S. Food ... first medical scalp cooling device to receive FDA clearance. ... patented tight-fitting silicone cooling cap that is placed directly ...
(Date:12/8/2016)... Ariz., Dec. 8, 2016  Economic growth in the ... purchasing and supply management executives in their December 2016 ... the economic recovery that began in mid-2009, as indicated ... Business ® . The manufacturing sector is optimistic ... in 16 manufacturing industries, and the non-manufacturing sector indicates ...
Breaking Medicine Technology: